نتائج البحث - "Davide Melisi"

1

Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study

المؤلفون: Francesco Caputo, Fabio Gelsomino, Andrea Spallanzani, Elisa Pettorelli, Stefania Benatti, Michele Ghidini, Giulia Grizzi, Margherita Ratti, Valeria Merz, Carlo Messina, Roberto Tonelli, Gabriele Luppi, Davide Melisi, Massimo Dominici, Massimiliano Salati

مصطلحات موضوعية: Hepatology, Survival, Neutrophils, Gastroenterology, Long-term survivors, Biliary cancer, Chemotherapy, Cholangiocarcinoma, Gallbladder cancer, Prognosis, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Lymphocytes, Survivors, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb1e91a3454d7a030a305430f818396fTest
https://hdl.handle.net/11562/1087017Test

2

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib

المؤلفون: Davide Melisi, Silvia Pietrobono

المصدر: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 3, Pp 1151-1152 (2021)

مصطلحات موضوعية: Male, DFS, disease-free survival, Drug Resistance, IC50, half maximal inhibitory concentration, RC799-869, DMSO, dimethyl sulfoxide, Mice, GSEA, gene set enrichment analysis, SR, sorafenib-resistant, GEO, Gene Expression Omnibus, NF-κB, nuclear factor kappa B, Original Research, Liver Neoplasms, Gastroenterology, RNA-Binding Proteins, IP, immunoprecipitation, RIP, RNA immunoprecipitation, Hep G2 Cells, Diseases of the digestive system. Gastroenterology, Sorafenib, TAK1, transforming growth factor-β–activated kinase 1, MAP Kinase Kinase Kinases, Up-Regulation, Gene Expression Regulation, Neoplastic, Editorial, Hepatocellular carcinoma, qPCR, quantitative polymerase chain reaction, EMT, epithelial-mesenchymal transition, NASH, nonalcoholic steatohepatitis, IHC, immunohistochemistry, medicine.drug, Carcinoma, Hepatocellular, TAK1, CHX, cycloheximide, Cell Line, Tumor, medicine, Animals, Humans, neoplasms, Cell Proliferation, Hepatology, business.industry, F-Box Proteins, Phenylurea Compounds, Carcinoma, TNF-α, tumor necrosis factor-alpha, Ubiquitination, Membrane Proteins, Hepatocellular, Hepatocellular Carcinoma, medicine.disease, Xenograft Model Antitumor Assays, digestive system diseases, SRRSH, Sir Run Run Shaw Hospital, Drug Resistance, Neoplasm, siRNA, small interfering RNA, Mutation, Proteolysis, Cancer research, Neoplasm, TCGA, The Cancer Genome Atlas, NAFLD, nonalcoholic fatty liver disease, RT, real-time, business, Ubiquitin-Mediated Proteolysis, HCC, hepatocellular carcinoma, OXO, 5z-7-oxozeaenol, DAPI, 4′,6-diamidino-2-phenylindole

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1706b9fa09815f0c5c3763fe5dbd15fTest
https://pubmed.ncbi.nlm.nih.gov/33962073Test

3

Targeting KRAS: The Elephant in the Room of Epithelial Cancers

المؤلفون: Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli, Michele Milella, Vita Fedele, Davide Melisi

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25b41fab8480d742cf18850bc72549dTest
http://hdl.handle.net/11562/1044674Test

4

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities

المؤلفون: Davide Melisi, Claudio Luchini, Alessandro Cavaliere, Salvatore Terrazzino, Rita T. Lawlor, Michele Milella, Jae Il Shin, Roberto Salvia, Aldo Scarpa, Sarah Cargnin, Gaetano Paolino, Giuseppe Malleo, Marina Gaule, Maria L. Piredda, Paola Mattiolo

المصدر: Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-10 (2020)

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, BRAF, KRAS, MSI, dMMR, fusion genes, pancreatic cancer, Cancer Research, endocrine system diseases, Antineoplastic Agents, Review, medicine.disease_cause, lcsh:RC254-282, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, 0302 clinical medicine, Pancreatic cancer, Medicine, Humans, Molecular Targeted Therapy, Pathology, Molecular, neoplasms, business.industry, Molecular pathology, Kinase, Wild type, Microsatellite instability, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, digestive system diseases, Pancreatic Neoplasms, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Mutation, Cancer research, DNA mismatch repair, business, Carcinoma, Pancreatic Ductal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b281c8ffa9b245cf7fece84ed512056aTest
http://hdl.handle.net/11562/1028368Test

5

The development of PARP as a successful target for cancer therapy

المؤلفون: Davide Melisi, Elisabetta Grego, Giampaolo Tortora, Francesca Simionato, Roberto Iacovelli, Sara Cingarlini, Chiara Ciccarese, Emilio Bria, Roberto Ferrara

المصدر: Expert Review of Anticancer Therapy. 18:161-175

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4e3f2757aad379354ef48e9aedc143Test
https://doi.org/10.1080/14737140.2018.1419870Test

6

HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

المصدر: International Journal of Cancer. 139:2859-2864

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::46ed86b2f5e331435bc134bfc4bd3432Test
https://doi.org/10.1002/ijc.30408Test

7

Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma

المساهمون: Mottini, C, Tomihara, H, Carrella, D, Lamolinara, A, Iezzi, M, Huang, Jk, Amoreo, Ca, Buglioni, S, Manni, I, Robinson, F, Minelli, R, Kang, Y, Fleming, Jb, Kim, Mp, Bristow, Ca, Trisciuoglio, D, Iuliano, A, Del Bufalo, D, Di Bernardo, D, Melisi, D, Draetta, Gf, Ciliberto, G, Carugo, A, Cardone, L.

المصدر: Cancer research (Chic. Ill.) 79 (2019): 5612–5625. doi:10.1158/0008-5472.CAN-19-0187
info:cnr-pdr/source/autori:Mottini C.; Tomihara H.; Carrella D.; Lamolinara A.; Iezzi M.; Huang J.K.; Amoreo C.A.; Buglioni S.; Manni I.; Robinson F.S.; Minelli R.; Kang Y.; Fleming J.B.; Kim M.P.; Bristow C.A.; Trisciuoglio D.; Iuliano A.; Bufalo D.D.; Bernardo D.D.; Melisi D.; Draetta G.F.; Ciliberto G.; Carugo A.; Cardone L./titolo:Predictive signatures inform the effective repurposing of decitabine to treat KRAS-dependent pancreatic ductal adenocarcinoma/doi:10.1158%2F0008-5472.CAN-19-0187/rivista:Cancer research (Chic. Ill.)/anno:2019/pagina_da:5612/pagina_a:5625/intervallo_pagine:5612–5625/volume:79

مصطلحات موضوعية: 0301 basic medicine, Drug, Cancer Research, endocrine system diseases, media_common.quotation_subject, pancreatic cancer, Decitabine, Mice, SCID, Adenocarcinoma, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Mice, 0302 clinical medicine, Mice, Inbred NOD, Pancreatic cancer, Cell Line, Tumor, KRAS, medicine, Carcinoma, Animals, Humans, neoplasms, Protein Kinase Inhibitors, Repurposing, media_common, business.industry, Drug Repositioning, Gene signature, medicine.disease, digestive system diseases, respiratory tract diseases, Pancreatic Neoplasms, 030104 developmental biology, Pyrimidines, Oncology, 030220 oncology & carcinogenesis, Cancer cell, Mutation, Cancer research, business, medicine.drug, Carcinoma, Pancreatic Ductal, Signal Transduction